GoingToMeet

The Seventh International Colorectal Cancer Congress is dedicated to an in-depth discussion of the best care options for the comprehensive management of patients with colorectal cancer. A significant emphasis will be given to case-based clinical scenarios in order to provide a forum for discussion, and expert opinion leaders will debate current controversies on the application of emerging clinical trial findings to daily practice. The optimal integration of biologic agents, such as EGFR inhibitors, antiangiogenic agents, and other novel agents, into current chemotherapy regimens will be addressed. Multidisciplinary approaches to the treatment of rectal cancer will be discussed, including developments in radiation therapy, surgery, and chemotherapy treatments. Participants will also gain insight into the pharmacogenomics of colorectal cancer and how this knowledge will aid in the prediction and prognostication of treatment response. The goal of this congress is for participants to integrate the latest advances in the treatment of colorectal cancer into their daily practice as well as to discuss future directions in research and clinical trials.